Protherics plc


Public list: Pharma Startups (4740) Cancer Therapeutics (1146)

Protherics is an international biopharmaceutical company focused on specialist products for critical care and cancer.nThe Company has two critical care products, CroFab and DigiFab, approved for sale in the US. The Company has the opportunity to sell these products in the US from October 2010 together with Voraxaze, a supportive cancer care product, following anticipated approval in the US in 2010. Protherics is also developing a number of other products in the cancer arena that it can commerci...Show all

Protherics is an international biopharmaceutical company focused on specialist products for critical care and cancer.nThe Company has two critical care products, CroFab and DigiFab, approved for sale in the US. The Company has the opportunity to sel...Show all

Company (Alive / Active)

Phone:

Fax:

Northern House Woodsome Park
Fenay Bridge Huddersfield West
HD8 0LA
United Kingdom

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Protherics plc $0M Mar 19, 2019
See all 15 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Protherics plc Jobs

jobs by Indeed job
						search
There is no Investors data available for this company. Please select another tab.
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Biodel

Danbury, Connecticut, United States
IPO / Went publicBiodel Inc. is a biopharmaceutical drug delivery company. Biodel develops drug delivery technologies that increase drug efficacy, enhance drug performance, and make drugs easier for patients to take. This technology is applicable to a wide range of peptides, proteins and other macromolecules. Using this technology, Biodel has developed a drug formulation of recombinant human insulin designed to speed the delivery of insulin into the blood called ViajectTM to treat patients with Type 1 and Type 2...Show allLogin to see details

ForSight VISION4

Menlo Park, California, United States
AcquiredForSight Labs is a community of ophthalmic innovation focused on developing and applying solutions to improve the sight, care, and quality of life of visually impaired patients.Login to see details
See all 15 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)